Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics

References

• Yan W, Wistuba II, Emmert-Buck MR, Erickson HS. Squamous cell carcinoma - Similarities and differences among anatomical sites. Am J Cancer Res 2011;1:275–300.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Mikelis CM, Zhang Y, Gutkind JS, Zhang B. TRAIL induces apoptosis in oral squamous carcinoma cells – a crosstalk with oncogenic Ras regulated cell surface expression of death receptor 5. Oncotarget 2013;4:206–17.
   PubMedGoogle Scholar
• Aquino G, Sabatino R, Cantile M, Aversa C, Ionna F, Botti G, et al. Expression analysis of SPARC/osteonectin in oral squamous cell carcinoma patients: from saliva to surgical specimen. Biomed Res Int 2013;2013:736438.
   PubMedGoogle Scholar
• Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin 2002;52:195–215.
   PubMed Web of Science ®Google Scholar
• Sciubba JJ. Oral cancer and its detection. History-taking and the diagnostic phase of management. J Am Dent Assoc 2001;132(Suppl):12S–8S; Erratum in: J Am Dent Assoc 2002;133:422.
   PubMedGoogle Scholar
• Rivera C, Venegas B. Histological and molecular aspects of oral squamous cell carcinoma (Review). Oncol Lett 2014;8:7–11.
   PubMed Web of Science ®Google Scholar
• Koontongkaew S. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and necksquamous cell carcinomas. J Cancer 2013;4:66–83.
   PubMed Web of Science ®Google Scholar
• Ohnishi Y, Watanabe M, Wato M, Tanaka A, Kakudo K, Nozaki M. Cyclin D1 expression is correlated with cell differentiation and cell proliferation in oral squamous cell carcinomas. Oncol Lett 2014;7:1123–7.
   PubMedGoogle Scholar
• Brinkman BM, Wong DT. Disease mechanism and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol 2006;18:228–33.
   PubMed Web of Science ®Google Scholar
• Shamaa AA, Zyada MM, Wagner M, Awad SS, Osman MM, Abdel Azeem AA. The significance of Epstein Barr virus (EBV) & DNA topoisomerase II alpha (DNA-Topo II alpha) immunoreactivity in normal oral mucosa, oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC). Diagn Pathol 2008;3:45.
   PubMedGoogle Scholar
• Lukesova E, Boucek J, Rotnaglova E, Salakova M, Koslabova E, Grega M, et al. High level of tregs is a positive prognostic marker in patients with HPV-Positive oral and oropharyngeal squamous cell carcinomas. Biomed Res Int 2014;2014:303929.
   PubMed Web of Science ®Google Scholar
• Prasad G, McCullough M. Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral cancer. Int J Dent 2013;2013:813756.
   PubMedGoogle Scholar
• Soon WW1, Hariharan M, Snyder MP. High-throughput sequencing for biology and medicine. Mol Syst Biol 2013;9:640.
   PubMed Web of Science ®Google Scholar
• Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov 2013;3:770–81.
   PubMed Web of Science ®Google Scholar
• Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov 2013;3:770–81.
   PubMed Web of Science ®Google Scholar
• Jithesh PV, Risk JM, Schache AG, Dhanda J, Lane B, Liloglou T, et al. The epigenetic landscape of oral squamous cell carcinoma. Br J Cancer 2013;108:370–9.
   Google Scholar
• Kim KY, Ki DH, Jeung HC, Chung HC, Rha SY. Improving the prediction accuracy in classification using the combined data sets by ranks of gene expressions. BMC Bioinformatics 2008;9:283.
   PubMed Web of Science ®Google Scholar
• Choi P, Chen C. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer 2005;104:1113–28.
   PubMed Web of Science ®Google Scholar
• Kim KY, Cha IH. Possibility of the use of public microarray database for identifying significant genes associated with oral squamous cell carcinoma. Genomics Inform 2012;10:23–32.
   PubMedGoogle Scholar
• Rentoft M, Coates PJ, Loljung L, Wilms T, Laurell G, Nylander K. Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue. Tumour Biol 2014;35:4191–8.
   PubMedGoogle Scholar
• Rentoft M, Laurell G, Coates PJ, Sjöström B, Nylander K. Gene expression profiling of archival tongue squamous cell carcinomas provides sub-classification based on DNA repair genes. Int J Oncol 2009;35:1321–30.
   PubMedGoogle Scholar
• Ishigami T, Uzawa K, Higo M, Nomura H, Saito K, Kato Y, et al. Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells. Int J Cancer 2007;120:2262–70.
   PubMedGoogle Scholar
• Parris TZ, Aziz L, Kovács A, Hajizadeh S, Nemes S, Semaan M, et al. Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma. BMC Cancer 2014;14:324.
   PubMed Web of Science ®Google Scholar
• Ries J, Vairaktaris E, Agaimy A, Kintopp R, Baran C, Neukam FW, et al. miR-186, miR-3651 and miR-494: potential biomarkers for oral squamous cell carcinoma extracted from whole blood. Oncol Rep 2014;31:1429–36.
   PubMed Web of Science ®Google Scholar
• Lajer CB, Nielsen FC, Friis-Hansen L, Norrild B, Borup R, Garnæs E, et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer 2011;104:830–40.
   PubMed Web of Science ®Google Scholar
• Huang WC, Chan SH, Jang TH, Chang JW, Ko YC, Yen TC, et al. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Cancer Res 2014;74:751–64.
   PubMed Web of Science ®Google Scholar
• Wiklund ED, Gao S, Hulf T, Sibbritt T, Nair S, Costea DE, et al. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS One 2011;6:e27840.
   PubMed Web of Science ®Google Scholar
• Bertero T, Bourget-Ponzio I, Puissant A, Loubat A, Mari B, Meneguzzi G, et al. Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties. Cell Cycle 2013;12:2183–93.
   PubMed Web of Science ®Google Scholar
• Tang H, Wu Z, Zhang J, Su B. Salivary lncRNA as a potential marker for oral squamous cell carcinoma diagnosis. Mol Med Rep 2013;7:761–6.
   PubMed Web of Science ®Google Scholar
• Gibb EA, Enfield KS, Stewart GL, Lonergan KM, Chari R, Ng RT, et al. Long non-coding RNAs are expressed in oral mucosa and altered in oral premalignant lesions. Oral Oncol 2011;47:1055–61.
   PubMed Web of Science ®Google Scholar
• Fang Z, Wu L, Wang L, Yang Y, Meng Y, Yang H. Increased expression of the long non-coding RNA UCA1 in tongue squamous cell carcinomas: a possible correlation with cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol 2014;117:89–95.
   PubMed Web of Science ®Google Scholar
• Kong XP, Yao J, Luo W, Feng FK, Ma JT, Ren YP, et al. The expression and functional role of a FOXC1 related mRNA-lncRNA pair in oral squamous cell carcinoma. Mol Cell Biochem 2014;394:177–86.
   PubMedGoogle Scholar
• Gao W, Chan JY, Wong TS. Long non-coding RNA deregulation in tongue squamous cell carcinoma. Biomed Res Int 2014;2014:405860.
   PubMed Web of Science ®Google Scholar
• Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011;333:1157–60.
   PubMed Web of Science ®Google Scholar
• Li R, Faden DL, Fakhry C, Langelier C, Jiao Y, Wang Y, et al. Clinical, genomic and metagenomic characterization of oral tongue squamous cell carcinoma in patients who do not smoke. Head Neck 2014; 10.1002/hed.23807.
   Google Scholar
• Pushalkar S, Mane SP, Ji X, Li Y, Evans C, Crasta OR, et al. Microbial diversity in saliva of oral squamous cell carcinoma. FEMS Immunol Med Microbiol 2011;61:269–77.
   PubMedGoogle Scholar
• Pushalkar S, Ji X, Li Y, Estilo C, Yegnanarayana R, Singh B, et al. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol 2012;12:144.
   PubMed Web of Science ®Google Scholar
• Herrmann PC, Liotta LA, Petricoin EF. Cancer proteomics: the state of the art. Dis Markers 2001;17:49–57.
   PubMed Web of Science ®Google Scholar
• Turhani D, Krapfenbauer K, Thurnher D, Langen H, Fountoulakis M. Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 2006;27:1417–23.
   PubMed Web of Science ®Google Scholar
• Wu JY, Yi C, Chung HR, Wang DJ, Chang WC, Lee SY, et al. Potential biomarkers in saliva for oral squamous cell carcinoma. Oral Oncol 2010;46:226–31.
   PubMed Web of Science ®Google Scholar
• Mlynarek AM, Balys RL, Su J, Hier MP, Black MJ, Alaoui-Jamali MA. A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2007;133:910–18.
   PubMedGoogle Scholar
• Lo WY, Tsai MH, Tsai Y, Hua CH, Tsai FJ, Huang SY, et al. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta 2007;376:101–7.
   PubMed Web of Science ®Google Scholar
• Lo WY, Lai CC, Hua CH, Tsai MH, Huang SY, Tsai CH, et al. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. J Proteome Res 2007;6:2143–51.
   PubMedGoogle Scholar
• Lai CH, Chang NW, Lin CF, Lin CD, Lin YJ, Wan L, et al. Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma. Clin Chim Acta 2010;411:984–91.
   PubMed Web of Science ®Google Scholar
• Shintani S, Hamakawa H, Ueyama Y, Hatori M, Toyoshima T. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Int J Oral Maxillofac Surg 2010;39:68–74.
   PubMed Web of Science ®Google Scholar
• Negishi A, Masuda M, Ono M, Honda K, Shitashige M, Satow R, et al. Quantitative proteomics using formalin-fixed paraffin-embedded tissues of oral squamous cell carcinoma. Cancer Sci 2009;100:1605–11.
   PubMed Web of Science ®Google Scholar
• Wang Z, Jiang L, Huang C, Li Z, Chen L, Gou L, et al. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol Cell Proteomics 2008;7:1639–50.
   PubMed Web of Science ®Google Scholar
• Jancsik VA, Gelencser G, Maasz G, Schmidt J, Molnar GA, Wittmann I, et al. Salivary proteomic analysis of diabetic patients for possible oral squamous cell carcinoma biomarkers. Pathol Oncol Res 2014;20:591–5.
   PubMedGoogle Scholar
• Sivadasan P, Palit P, Pinto S, Sekhar N, Harsha HC, Pandey A, et al. Salivary proteome for diagnosis and prognosis of oral cancer. Oral Oncol 2013. 49:S27. Available at http://dx.org/10.1016/j.oraloncology.2013.03.064.
   Google Scholar
• Prasad G, McCullough M. Chemokines and cytokines as salivary biomarkers for the early diagnosis of oral cancer. Int J Dent 2013;2013:813756.
   PubMedGoogle Scholar
• St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2004;130:929–35.
   PubMed Web of Science ®Google Scholar
• Zhang A, Sun H, Wang P, Wang X. Salivary proteomics in biomedical research. Clin Chim Acta 2013;415:261–5.
   PubMed Web of Science ®Google Scholar
• Oliveira-Neto HH, de Souza PP, da Silva MR, Mendonça EF, Silva TA, Batista AC. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis. Tumor Biol 2013;34:65–70.
   PubMedGoogle Scholar